Myogenin Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Myogenin antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMyogenin
Clone[F5D]
Host SpeciesMouse
Reactive Specieshuman, dog, rat, mouse
IsotypeIgG1/k
Formatunconjugated
Size5 Control Slides, 0.1 mL (Concentrate), 3 ml (Prediluted)
Concentrationn/a
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionMyogenin is a transcription factor active in muscles. In particular, it is a myogenic regulatory factor. Myogenin is a member of a family of myogenic regulatory genes, which includes MyoD, myf5 and MRF4. These genes encode a set of transcription factors which are essential for muscle development. Expression of myogenin is restricted to cells of skeletal-muscle origin. It is, therefore, a useful marker for tumors of the muscle lineage, being strongly expressed in Alveolar Rhabdomyosarcomas. Anti-myogenin labels the nuclei of myoblasts in developing muscle tissue, and is expressed in tumor cell nuclei of Rhabdomyosarcoma and some Leiomyosarcomas. Positive nuclear staining may occur in Wilm's Tumor.
Immunogenn/a
Other Names[myogenin; Myogenin; myogenin; myf-4; myogenic factor 4; OTTHUMP00000039094; Myogenic factor-4; myogenin; class C basic helix-loop-helix protein 3; myogenin (myogenic factor 4); Class C basic helix-loop-helix protein 3; bHLHc3; Myogenic factor 4], [MYOG; MYOG; MYF4; bHLHc3; MYOGENIN; BHLHC3; MYF4]
Gene, Accession #Gene ID: 4656, NCBI: NP_002470.2, UniProt: P15173
Catalog #MBS370091
Price$180, $180, $210
Order / More InfoMyogenin Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.